Market Closed -
Nasdaq
03:59:47 2024-06-04 pm EDT
|
5-day change
|
1st Jan Change
|
6.675
USD
|
-0.37%
|
|
-3.68%
|
+26.66%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
861.3
|
161.7
|
331.8
|
427.6
|
-
|
-
|
Enterprise Value (EV)
1 |
1,175
|
547.9
|
331.8
|
755.6
|
703.6
|
645.5
|
P/E ratio
|
34
x
|
-1.01
x
|
-2.12
x
|
-83.1
x
|
92.2
x
|
12.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2
x
|
0.32
x
|
0.65
x
|
0.79
x
|
0.74
x
|
0.72
x
|
EV / Revenue
|
2.73
x
|
1.07
x
|
0.65
x
|
1.39
x
|
1.22
x
|
1.09
x
|
EV / EBITDA
|
14.5
x
|
8.26
x
|
3.73
x
|
7.86
x
|
6.74
x
|
-
|
EV / FCF
|
75.2
x
|
-23.2
x
|
-
|
17
x
|
12.1
x
|
8.28
x
|
FCF Yield
|
1.33%
|
-4.3%
|
-
|
5.9%
|
8.26%
|
12.1%
|
Price to Book
|
2.38
x
|
0.64
x
|
-
|
1.94
x
|
1.79
x
|
1.6
x
|
Nbr of stocks (in thousands)
|
59,438
|
61,952
|
62,966
|
63,828
|
-
|
-
|
Reference price
2 |
14.49
|
2.610
|
5.270
|
6.700
|
6.700
|
6.700
|
Announcement Date
|
3/10/22
|
3/31/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
340.1
|
321.2
|
430.9
|
512.1
|
512.3
|
543
|
574.5
|
594.4
|
EBITDA
1 |
-
|
72.44
|
80.76
|
66.31
|
88.86
|
96.16
|
104.4
|
-
|
EBIT
1 |
31.19
|
58.61
|
85.36
|
47.95
|
81.05
|
83.58
|
94.42
|
97.54
|
Operating Margin
|
9.17%
|
18.25%
|
19.81%
|
9.36%
|
15.82%
|
15.39%
|
16.43%
|
16.41%
|
Earnings before Tax (EBT)
1 |
-
|
15.91
|
7.62
|
-263.9
|
-121.1
|
-19.04
|
-5.991
|
-
|
Net income
1 |
-
|
4.383
|
19.38
|
-158.7
|
-156.2
|
-0.5527
|
8.09
|
35.9
|
Net margin
|
-
|
1.36%
|
4.5%
|
-30.99%
|
-30.49%
|
-0.1%
|
1.41%
|
6.04%
|
EPS
2 |
-
|
0.8900
|
0.4261
|
-2.590
|
-2.490
|
-0.0807
|
0.0727
|
0.5535
|
Free Cash Flow
1 |
-
|
67.71
|
15.62
|
-23.58
|
-
|
44.55
|
58.1
|
78
|
FCF margin
|
-
|
21.08%
|
3.63%
|
-4.6%
|
-
|
8.2%
|
10.11%
|
13.12%
|
FCF Conversion (EBITDA)
|
-
|
93.46%
|
19.34%
|
-
|
-
|
46.33%
|
55.65%
|
-
|
FCF Conversion (Net income)
|
-
|
1,544.74%
|
80.62%
|
-
|
-
|
-
|
718.15%
|
217.29%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/6/20
|
3/25/21
|
3/10/22
|
3/31/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
130.4
|
117.3
|
140.3
|
137.1
|
125.8
|
119.1
|
137.1
|
120.8
|
135.4
|
129.5
|
137.6
|
131
|
145
|
138.7
|
146.8
|
EBITDA
1 |
28.49
|
7.111
|
22.93
|
22.66
|
15.23
|
16.95
|
28.16
|
21.74
|
22.02
|
22.62
|
25.36
|
20.95
|
27.36
|
23.85
|
27.71
|
EBIT
1 |
22.29
|
1.92
|
18.32
|
17.55
|
11.79
|
13.52
|
27.6
|
20.4
|
19.53
|
20.1
|
21.67
|
19.45
|
25.46
|
21.86
|
25.72
|
Operating Margin
|
17.09%
|
1.64%
|
13.05%
|
12.8%
|
9.37%
|
11.35%
|
20.14%
|
16.88%
|
14.42%
|
15.52%
|
15.75%
|
14.84%
|
17.55%
|
15.76%
|
17.52%
|
Earnings before Tax (EBT)
1 |
-4.618
|
-19.94
|
-6.77
|
3.184
|
-49.71
|
-100.2
|
-6.49
|
-8.191
|
-8.406
|
-5.075
|
-5.123
|
-8.35
|
-0.4805
|
-4.153
|
-0.1045
|
Net income
1 |
-
|
-11.28
|
-
|
-
|
-
|
-174.4
|
-3.681
|
-7.303
|
-6.096
|
-5.982
|
-7.1
|
-9.1
|
-2.3
|
-4.1
|
-1.3
|
Net margin
|
-
|
-9.61%
|
-
|
-
|
-
|
-146.52%
|
-2.69%
|
-6.05%
|
-4.5%
|
-4.62%
|
-5.16%
|
-6.94%
|
-1.59%
|
-2.96%
|
-0.89%
|
EPS
2 |
-0.0100
|
-0.1900
|
-0.1100
|
0.0300
|
-0.5200
|
-2.240
|
-0.0700
|
-0.1200
|
-0.1000
|
-0.0700
|
-0.0196
|
-0.0607
|
0.0396
|
-0.0600
|
0.005000
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/10/22
|
5/10/22
|
8/11/22
|
11/8/22
|
3/31/23
|
5/16/23
|
8/8/23
|
11/7/23
|
3/12/24
|
5/7/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
102
|
314
|
386
|
-
|
328
|
276
|
218
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
1.402
x
|
3.885
x
|
5.825
x
|
-
|
3.411
x
|
2.643
x
|
-
|
Free Cash Flow
1 |
-
|
67.7
|
15.6
|
-23.6
|
-
|
44.6
|
58.1
|
78
|
ROE (net income / shareholders' equity)
|
-
|
26%
|
22.3%
|
1.9%
|
-
|
7.67%
|
12%
|
14.1%
|
ROA (Net income/ Total Assets)
|
-
|
7.67%
|
7.8%
|
0.57%
|
-
|
2.1%
|
3.43%
|
4.39%
|
Assets
1 |
-
|
57.18
|
248.3
|
-27,974
|
-
|
-26.32
|
236.2
|
818.1
|
Book Value Per Share
2 |
-
|
2.500
|
6.090
|
4.070
|
-
|
3.450
|
3.740
|
4.180
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
4.09
|
7.37
|
10
|
-
|
7.15
|
8
|
8
|
Capex / Sales
|
-
|
1.27%
|
1.71%
|
1.96%
|
-
|
1.32%
|
1.39%
|
1.35%
|
Announcement Date
|
10/6/20
|
3/25/21
|
3/10/22
|
3/31/23
|
3/12/24
|
-
|
-
|
-
|
Average target price
8.5
USD Spread / Average Target +26.87% Consensus |
1st Jan change
|
Capi.
|
---|
| +26.66% | 428M | | +75.69% | 12.57B | | -24.12% | 7.4B | | +10.90% | 6.9B | | +20.88% | 5.79B | | -16.36% | 4.86B | | +19.43% | 4.27B | | -18.62% | 3.96B | | -24.00% | 2.87B | | +52.88% | 2.46B |
Medical Equipment
|